ArticleFrontiers in oncology2025
Case Report: Shadows of disappearance: the enigma of completely regressed cutaneous melanoma revealed by lymph node metastasis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cutaneous malignant melanoma is an aggressive neoplasm with high metastatic potential. Complete spontaneous regression of the primary lesion is rare, poorly understood, and often leads to diagnostic challenges, particularly when the cutaneous origin is no longer clinically or histologically evident. We report two cases of completely regressed cutaneous melanoma that initially presented as unexplained lymphadenopathy and were diagnosed through fine needle aspiration cytology (FNAC) and pathological examination. Both patients were admitted to non-dermatological departments due to regional lymphadenopathy. FNAC of the lymph nodes revealed malignant cells with features suggestive of melanoma. In both cases, immunocytochemical staining of cell block preparations confirmed melanocytic origin, with positivity for SOX10, HMB45, and Melan-A, and negativity for markers excluding hematolymphoid and epithelial neoplasms. Notably, neither patient had a prior history of malignancy. One patient had been misdiagnosed with onychomycosis for two years, reevaluation revealed a regressed subungual lesion while the other patient described a longstanding black lesion on the fifth fingertip that spontaneously resolved without nail involvement. These cases highlight the crucial role of cytology and immunohistochemistry in the diagnosis of metastatic melanoma when the primary lesion has fully regressed. They underscore the need for a high index of suspicion, comprehensive clinical history, and close collaboration between clinicians, cytopathologists, and dermatologists. Greater awareness of this rare presentation is essential to prevent misdiagnosis and ensure timely and accurate treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.